David McMahon, MBA, MS is the Founder and CEO of MG Therapies Inc., a revenue stage company in the ophthalmology space focused on treating Dry Eye Disease. Mr. McMahon has over 20 years of medical device experience developing and commercializing medical devices in Fortune 10 corporations as well as a founder of multiple medical product start-ups. Mr McMahon’s corporate experience includes executive positions with: Applied Medical, Alaris Medical, Cardinal Health and Luminous Medical. He has been directly involved in commercializing 10 FDA Class II devices and numerous Class I devices in his career.